Fundamental and intensive care of acute pancreatitis

Morihisa Hirota, Tadahiro Takada, Nobuya Kitamura, Tetsuhide Ito, Koichi Hirata, Masahiro Yoshida, Toshihiko Mayumi, Keisho Kataoka, Kazunori Takeda, Miho Sekimoto, Masahiko Hirota, Yasutoshi Kimura, Keita Wada, Hodaka Amano, Toshifumi Gabata, Shinju Arata, Masamichi Yokoe, Seiki Kiriyama

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Patients who have been diagnosed as having acute pancreatitis should be, on principle, hospitalized. Crucial fundamental management is required soon after a diagnosis of acute pancreatitis has been made and includes monitoring of the conscious state, the respiratory and cardiovascular system, the urinary output, adequate fluid replacement and pain control. Along with such management, etiologic diagnosis and severity assessment should be conducted. Patients with a diagnosis of severe acute pancreatitis should be transferred to a medical facility where intensive respiratory and cardiovascular management as well as interventional treatment, blood purification therapy and nutritional support are available. The disease condition in acute pancreatitis changes every moment and even symptoms that are mild at the time of diagnosis may become severe later. Therefore, severity assessment should be conducted repeatedly at least within 48 h following diagnosis. An adequate dose of fluid replacement is essential to stabilize cardiovascular dynamics and the dose should be adjusted while assessing circulatory dynamics constantly. A large dose of fluid replacement is usually required in patients with severe acute pancreatitis. Prophylactic antibiotic administration is recommended to prevent infectious complications in patients with severe acute pancreatitis. Although the efficacy of intravenous administration of protease inhibitors is still a matter of controversy, there is a consensus in Japan that a large dose of a synthetic protease inhibitor should be given to patients with severe acute pancreatitis in order to prevent organ failure and other complications. Enteral feeding is superior to parenteral nutrition when it comes to the nutritional support of patients with severe acute pancreatitis. The JPN Guidelines recommend, as optional continuous regional arterial infusion and blood purification therapy.

Original languageEnglish
Pages (from-to)45-52
Number of pages8
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 1 2010

Fingerprint

Critical Care
Pancreatitis
Nutritional Support
Protease Inhibitors
Intra Arterial Infusions
Parenteral Nutrition
Enteral Nutrition
Cardiovascular System
Intravenous Administration
Respiratory System
Consensus
Japan
Therapeutics
Guidelines
Anti-Bacterial Agents
Pain

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hirota, M., Takada, T., Kitamura, N., Ito, T., Hirata, K., Yoshida, M., ... Kiriyama, S. (2010). Fundamental and intensive care of acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Sciences, 17(1), 45-52. https://doi.org/10.1007/s00534-009-0210-7

Fundamental and intensive care of acute pancreatitis. / Hirota, Morihisa; Takada, Tadahiro; Kitamura, Nobuya; Ito, Tetsuhide; Hirata, Koichi; Yoshida, Masahiro; Mayumi, Toshihiko; Kataoka, Keisho; Takeda, Kazunori; Sekimoto, Miho; Hirota, Masahiko; Kimura, Yasutoshi; Wada, Keita; Amano, Hodaka; Gabata, Toshifumi; Arata, Shinju; Yokoe, Masamichi; Kiriyama, Seiki.

In: Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 17, No. 1, 01.01.2010, p. 45-52.

Research output: Contribution to journalArticle

Hirota, M, Takada, T, Kitamura, N, Ito, T, Hirata, K, Yoshida, M, Mayumi, T, Kataoka, K, Takeda, K, Sekimoto, M, Hirota, M, Kimura, Y, Wada, K, Amano, H, Gabata, T, Arata, S, Yokoe, M & Kiriyama, S 2010, 'Fundamental and intensive care of acute pancreatitis', Journal of Hepato-Biliary-Pancreatic Sciences, vol. 17, no. 1, pp. 45-52. https://doi.org/10.1007/s00534-009-0210-7
Hirota M, Takada T, Kitamura N, Ito T, Hirata K, Yoshida M et al. Fundamental and intensive care of acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Sciences. 2010 Jan 1;17(1):45-52. https://doi.org/10.1007/s00534-009-0210-7
Hirota, Morihisa ; Takada, Tadahiro ; Kitamura, Nobuya ; Ito, Tetsuhide ; Hirata, Koichi ; Yoshida, Masahiro ; Mayumi, Toshihiko ; Kataoka, Keisho ; Takeda, Kazunori ; Sekimoto, Miho ; Hirota, Masahiko ; Kimura, Yasutoshi ; Wada, Keita ; Amano, Hodaka ; Gabata, Toshifumi ; Arata, Shinju ; Yokoe, Masamichi ; Kiriyama, Seiki. / Fundamental and intensive care of acute pancreatitis. In: Journal of Hepato-Biliary-Pancreatic Sciences. 2010 ; Vol. 17, No. 1. pp. 45-52.
@article{f33b855a35164b06aaa546d8fc4d577e,
title = "Fundamental and intensive care of acute pancreatitis",
abstract = "Patients who have been diagnosed as having acute pancreatitis should be, on principle, hospitalized. Crucial fundamental management is required soon after a diagnosis of acute pancreatitis has been made and includes monitoring of the conscious state, the respiratory and cardiovascular system, the urinary output, adequate fluid replacement and pain control. Along with such management, etiologic diagnosis and severity assessment should be conducted. Patients with a diagnosis of severe acute pancreatitis should be transferred to a medical facility where intensive respiratory and cardiovascular management as well as interventional treatment, blood purification therapy and nutritional support are available. The disease condition in acute pancreatitis changes every moment and even symptoms that are mild at the time of diagnosis may become severe later. Therefore, severity assessment should be conducted repeatedly at least within 48 h following diagnosis. An adequate dose of fluid replacement is essential to stabilize cardiovascular dynamics and the dose should be adjusted while assessing circulatory dynamics constantly. A large dose of fluid replacement is usually required in patients with severe acute pancreatitis. Prophylactic antibiotic administration is recommended to prevent infectious complications in patients with severe acute pancreatitis. Although the efficacy of intravenous administration of protease inhibitors is still a matter of controversy, there is a consensus in Japan that a large dose of a synthetic protease inhibitor should be given to patients with severe acute pancreatitis in order to prevent organ failure and other complications. Enteral feeding is superior to parenteral nutrition when it comes to the nutritional support of patients with severe acute pancreatitis. The JPN Guidelines recommend, as optional continuous regional arterial infusion and blood purification therapy.",
author = "Morihisa Hirota and Tadahiro Takada and Nobuya Kitamura and Tetsuhide Ito and Koichi Hirata and Masahiro Yoshida and Toshihiko Mayumi and Keisho Kataoka and Kazunori Takeda and Miho Sekimoto and Masahiko Hirota and Yasutoshi Kimura and Keita Wada and Hodaka Amano and Toshifumi Gabata and Shinju Arata and Masamichi Yokoe and Seiki Kiriyama",
year = "2010",
month = "1",
day = "1",
doi = "10.1007/s00534-009-0210-7",
language = "English",
volume = "17",
pages = "45--52",
journal = "Journal of Hepato-Biliary-Pancreatic Sciences",
issn = "1868-6974",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Fundamental and intensive care of acute pancreatitis

AU - Hirota, Morihisa

AU - Takada, Tadahiro

AU - Kitamura, Nobuya

AU - Ito, Tetsuhide

AU - Hirata, Koichi

AU - Yoshida, Masahiro

AU - Mayumi, Toshihiko

AU - Kataoka, Keisho

AU - Takeda, Kazunori

AU - Sekimoto, Miho

AU - Hirota, Masahiko

AU - Kimura, Yasutoshi

AU - Wada, Keita

AU - Amano, Hodaka

AU - Gabata, Toshifumi

AU - Arata, Shinju

AU - Yokoe, Masamichi

AU - Kiriyama, Seiki

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Patients who have been diagnosed as having acute pancreatitis should be, on principle, hospitalized. Crucial fundamental management is required soon after a diagnosis of acute pancreatitis has been made and includes monitoring of the conscious state, the respiratory and cardiovascular system, the urinary output, adequate fluid replacement and pain control. Along with such management, etiologic diagnosis and severity assessment should be conducted. Patients with a diagnosis of severe acute pancreatitis should be transferred to a medical facility where intensive respiratory and cardiovascular management as well as interventional treatment, blood purification therapy and nutritional support are available. The disease condition in acute pancreatitis changes every moment and even symptoms that are mild at the time of diagnosis may become severe later. Therefore, severity assessment should be conducted repeatedly at least within 48 h following diagnosis. An adequate dose of fluid replacement is essential to stabilize cardiovascular dynamics and the dose should be adjusted while assessing circulatory dynamics constantly. A large dose of fluid replacement is usually required in patients with severe acute pancreatitis. Prophylactic antibiotic administration is recommended to prevent infectious complications in patients with severe acute pancreatitis. Although the efficacy of intravenous administration of protease inhibitors is still a matter of controversy, there is a consensus in Japan that a large dose of a synthetic protease inhibitor should be given to patients with severe acute pancreatitis in order to prevent organ failure and other complications. Enteral feeding is superior to parenteral nutrition when it comes to the nutritional support of patients with severe acute pancreatitis. The JPN Guidelines recommend, as optional continuous regional arterial infusion and blood purification therapy.

AB - Patients who have been diagnosed as having acute pancreatitis should be, on principle, hospitalized. Crucial fundamental management is required soon after a diagnosis of acute pancreatitis has been made and includes monitoring of the conscious state, the respiratory and cardiovascular system, the urinary output, adequate fluid replacement and pain control. Along with such management, etiologic diagnosis and severity assessment should be conducted. Patients with a diagnosis of severe acute pancreatitis should be transferred to a medical facility where intensive respiratory and cardiovascular management as well as interventional treatment, blood purification therapy and nutritional support are available. The disease condition in acute pancreatitis changes every moment and even symptoms that are mild at the time of diagnosis may become severe later. Therefore, severity assessment should be conducted repeatedly at least within 48 h following diagnosis. An adequate dose of fluid replacement is essential to stabilize cardiovascular dynamics and the dose should be adjusted while assessing circulatory dynamics constantly. A large dose of fluid replacement is usually required in patients with severe acute pancreatitis. Prophylactic antibiotic administration is recommended to prevent infectious complications in patients with severe acute pancreatitis. Although the efficacy of intravenous administration of protease inhibitors is still a matter of controversy, there is a consensus in Japan that a large dose of a synthetic protease inhibitor should be given to patients with severe acute pancreatitis in order to prevent organ failure and other complications. Enteral feeding is superior to parenteral nutrition when it comes to the nutritional support of patients with severe acute pancreatitis. The JPN Guidelines recommend, as optional continuous regional arterial infusion and blood purification therapy.

UR - http://www.scopus.com/inward/record.url?scp=77956091318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956091318&partnerID=8YFLogxK

U2 - 10.1007/s00534-009-0210-7

DO - 10.1007/s00534-009-0210-7

M3 - Article

C2 - 20012652

AN - SCOPUS:77956091318

VL - 17

SP - 45

EP - 52

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

SN - 1868-6974

IS - 1

ER -